Technology & Innovation

On October 6th, the renowned global logistics provider GEODIS commenced operations at its expansive 5,500 square-meter site in Schiphol. This newly established facility is dedicated to serving the pharmaceutical and healthcare sectors. Situated adjacent to the existing site, it will significantly enhance GEODIS' presence in the pharmaceutical and healthcare industries, which are already well-established at the company's Venlo site, particularly in the realm of contract logistics for clients in both sectors. The new investment in Schiphol-Rijk will primarily focus on freight forwarding and become an integral part of GEODIS' worldwide cross-docking network for both ambient and cold chain products. This state-of-the-art location holds a TAPA-A rating for air freight and boasts the CEIV Pharma certification, ensuring the proper handling of goods within the temperature ranges of 15-25 °C and 2-8 °C. Mark van den Assem, Managing Director of GEODIS Benelux, shared, "By adding this specialized warehouse at Schiphol-Rijk, we can offer our clients a comprehensive solution for pharmaceutical and healthcare logistics. Enhancing the synergy between our Contract Logistics and Freight Forwarding divisions is a pivotal component of our growth strategy and will significantly benefit our customers' supply chain requirements." GEODIS is a leading global logistics provider recognized for its expertise in all aspects of the supply chain. As a trusted growth partner for its clients, GEODIS specializes in five key areas: Supply Chain Optimization, Global Freight Forwarding, Global Contract Logistics, Distribution & Express, and the European Road Network. With a global presence spanning nearly 170 countries and a workforce of over 49,400 employees, GEODIS ranks as the 6th largest company in its sector worldwide. In 2022, GEODIS generated €13.7 billion in revenue. The company is a subsidiary of the SNCF group.